Literature DB >> 23538179

Hospitalization resource use and costs before and after TIA and stroke: results from a population-based cohort study (OXVASC).

Ramon Luengo-Fernandez1, Louise E Silver, Sergei A Gutnikov, Alastair M Gray, Peter M Rothwell.   

Abstract

OBJECTIVES: High hospitalization rates, prolonged length of stay, and increased risks of subsequent events mean a steep increase in health care usage after stroke. No study, however, has examined to what extent increased costs after transient ischemic attack (TIA) or stroke are due to hospitalizations for the initial event, recurrent events, and/or nonvascular hospitalizations, and how costs compare with the year prior to the event.
METHODS: We studied patients in a population-based cohort study (Oxford Vascular Study) in the United Kingdom from 2003 to 2007. Hospitalization and cost details were obtained from patients' individualized Hospital Episode Statistics records.
RESULTS: A total of 295 incident TIA and 439 incident stroke patients were included. For patients with stroke, average costs increased from £1437 in the year pre-event to £6629 in the year post-event (P<0.0001). Sixty-four percent (£4224) of poststroke costs were due to hospitalizations linked to the index stroke, more than 30% of which were given nonvascular primary diagnoses on Hospital Episode Statistics, and £653 (10%) were due to hospitalizations linked to subsequent vascular events. For patients with TIA, costs increased from £876 1 year before the event to £2410 in the year post-event (P<0.0001). Patients with TIA incurred nonsignificantly higher costs due to hospitalizations linked to subsequent vascular events (£774) than for hospitalizations linked to the index TIA (£720).
CONCLUSIONS: Hospital costs increased after TIA or stroke, primarily because of increased initial cerebrovascular hospitalizations. The finding that costs due to nonvascular diagnoses also increased after TIA or stroke appears, in part, to be explained by the miscoding of TIA/stroke-related hospitalizations in electronic information systems.
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23538179     DOI: 10.1016/j.jval.2012.10.013

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  8 in total

1.  Long-term morbidity and mortality in patients without early complications after stroke or transient ischemic attack.

Authors:  Jodi D Edwards; Moira K Kapral; Jiming Fang; Richard H Swartz
Journal:  CMAJ       Date:  2017-07-24       Impact factor: 8.262

Review 2.  TIA Management: Should TIA Patients be Admitted? Should TIA Patients Get Combination Antiplatelet Therapy?

Authors:  Christina Mijalski; Brian Silver
Journal:  Neurohospitalist       Date:  2015-07

3.  Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial.

Authors:  Kit N Simpson; Annie N Simpson; Patrick D Mauldin; Michael D Hill; Sharon D Yeatts; Judith A Spilker; Lydia D Foster; Pooja Khatri; Renee Martin; Edward C Jauch; Dawn Kleindorfer; Yuko Y Palesch; Joseph P Broderick
Journal:  Stroke       Date:  2014-05-13       Impact factor: 7.914

Review 4.  Emergency Department (ED) Triage for Transient Ischemic Attack (TIA).

Authors:  Carlo W Cereda; Jean-Marc Olivot
Journal:  Curr Atheroscler Rep       Date:  2018-09-25       Impact factor: 5.113

5.  A one-year cost-utility analysis of REBOA versus RTACC for non-compressible torso haemorrhage.

Authors:  Maxwell S Renna; Cristiano van Zeller; Farah Abu-Hijleh; Cherlyn Tong; Jasmine Gambini; Mengyao Ma
Journal:  Trauma       Date:  2017-11-24

6.  Long-Term Impact of Urgent Secondary Prevention After Transient Ischemic Attack and Minor Stroke: Ten-Year Follow-Up of the EXPRESS Study.

Authors:  Ramon Luengo-Fernandez; Linxin Li; Louise Silver; Sergei Gutnikov; Nicola C Beddows; Peter M Rothwell
Journal:  Stroke       Date:  2021-10-28       Impact factor: 7.914

7.  Validity of a stroke severity index for administrative claims data research: a retrospective cohort study.

Authors:  Sheng-Feng Sung; Cheng-Yang Hsieh; Huey-Juan Lin; Yu-Wei Chen; Chih-Hung Chen; Yea-Huei Kao Yang; Ya-Han Hu
Journal:  BMC Health Serv Res       Date:  2016-09-22       Impact factor: 2.655

8.  Cost-effectiveness of left ventricular assist devices as destination therapy in the United Kingdom.

Authors:  Stephan Schueler; Scott C Silvestry; William G Cotts; Mark S Slaughter; Wayne C Levy; Richard K Cheng; Jennifer A Beckman; Jonas Villinger; Eleni Ismyrloglou; Stelios I Tsintzos; Claudius Mahr
Journal:  ESC Heart Fail       Date:  2021-05-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.